BLOOD CANCER UNITED INC: Form 990, tax year 2023

View the entire original 990 at ProPublica ↗

Organization: BLOOD CANCER UNITED INC (EIN 13-5644916)
Tax period: 2023-07-01 to 2024-06-30
Filed: 2025-02-12
IRS object ID: 202500439349301505
Schema version: 2023v6.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2025-02-12T12:16:03-06:00	ReturnTs
Tax Period End	2024-06-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	135565207	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	KPMG LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	345 PARK AVENUE	AddressLine1Txt
City	NEW YORK	CityNm
State Abbreviation	NY	StateAbbreviationCd
ZIP	101540102	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2023-07-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	135644916	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	THE LEUKEMIA & LYMPHOMA SOCIETYINC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	LEUK	BusinessNameControlTxt
Phone	9149495213	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 15TH STREET NW SUITE 410	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	GORDON MILLER JR	PersonNm
Person Title	EVP CHIEF FINANCIAL OFFICER	PersonTitleTxt
Phone	9149495213	PhoneNum
Signature	2025-02-12	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Field	Value	IRS element (for citing)
IRS Responsible Prty Info Curr	0	IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	DEVIN L DUNCAN	PreparerPersonNm
PTIN	P01249521	PTIN
Phone	2127589700	PhoneNum

Field	Value	IRS element (for citing)
Tax	2023	TaxYr
Build TS	2025-03-06 01:10:19Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Address Change	Yes (X)	AddressChangeInd
Principal Officer	E ANDERS KOLB MD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 15TH STREET NW SUITE 410	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$569,282,300	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.LLS.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1949	FormationYr
Legal Domicile State	NY	LegalDomicileStateCd
Activity Or Mission	CURE LEUKEMIA,LYMPHOMA,HODGKIN'S DISEASE, MYELOMA; IMPROVE QUALITY OF LIFE OF PATIENTS AND FAMILIES.	ActivityOrMissionDesc
Voting Members Governing Body	20	VotingMembersGoverningBodyCnt
Voting Members Independent	20	VotingMembersIndependentCnt
Total Employee	1228	TotalEmployeeCnt
Total Volunteers	3000000	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$357,670,634	PYContributionsGrantsAmt
CY Contributions Grants	$338,611,733	CYContributionsGrantsAmt
PY Program Service Revenue	$9,531,279	PYProgramServiceRevenueAmt
CY Program Service Revenue	$14,932,514	CYProgramServiceRevenueAmt
PY Investment Income	$15,134,480	PYInvestmentIncomeAmt
CY Investment Income	$16,623,882	CYInvestmentIncomeAmt
PY Other Revenue	-$3,997,903	PYOtherRevenueAmt
CY Other Revenue	-$1,926,070	CYOtherRevenueAmt
PY Total Revenue	$378,338,490	PYTotalRevenueAmt
CY Total Revenue	$368,242,059	CYTotalRevenueAmt
PY Grants And Similar Paid	$147,771,106	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$119,474,064	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$119,899,883	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$137,851,341	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$4,917,672	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$4,745,743	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$44,198,758	CYTotalFundraisingExpenseAmt
PY Other Expenses	$113,484,307	PYOtherExpensesAmt
CY Other Expenses	$109,721,024	CYOtherExpensesAmt
PY Total Expenses	$386,072,968	PYTotalExpensesAmt
CY Total Expenses	$371,792,172	CYTotalExpensesAmt
PY Revenues Less Expenses	-$7,734,478	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	-$3,550,113	CYRevenuesLessExpensesAmt
Total Assets BOY	$643,891,871	TotalAssetsBOYAmt
Total Assets EOY	$602,010,519	TotalAssetsEOYAmt
Total Liabilities BOY	$271,338,303	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$211,058,338	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$372,553,568	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$390,952,181	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	OUR MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$133,673,729	ExpenseAmt
Grant	$64,361,276	GrantAmt
Revenue	$14,932,514	RevenueAmt
Desc	A) RESEARCH PROGRAMS:AT LLS, WE ARE PUSHING BOUNDARIES TOWARD POWERFUL NEW THERAPIES. WE PROPEL GROUNDBREAKING CANCER TREATMENTS THROUGH ALL PHASES OF THE DRUG APPROVAL PROCESS AND ARE PROUD THAT OUR SUPPORT HAS BEEN KEY TO ADVANCING 75% OF THE ALMOST 70 BLOOD CANCER TREATMENT APPROVALS OVER THE LAST FIVE YEARS.AS WE CONTINUED TO SUPPORT THE SEARCH FOR LIFESAVING AND LESS TOXIC TREATMENTS IN 2024, WE INVESTED IN EXCITING RESEARCH FRONTIERS, INCLUDING PRECISION MEDICINE, IMMUNOTHERAPY, AND LINKS BETWEEN MUTATIONS AND BLOOD CANCER-ADVANCEMENTS THAT ARE CHANGING THE PARADIGM OF CANCER TREATMENT. IN THE PROCESS, WE PROPELLED SEVERAL NOVEL SCIENCE INITIATIVES TO NEW HEIGHTS-MANY OF WHICH HARDLY SEEMED POSSIBLE JUST A SHORT TIME AGO. WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, LLS FUNDS EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVE OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS. AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. LLS IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS AS SOON AS POSSIBLE. IN ADDITION, WHILE LLS DEDICATES SUBSTANTIAL FUNDING TO ADVANCING NOVEL TREATMENTS FOR BLOOD CANCER, WE ALSO RECOGNIZE THAT IT IS EQUALLY IMPORTANT THAT WE COMMIT TO ENSURING THAT PATIENTS CAN ACCESS THESE ESSENTIAL THERAPIES. TO THIS END, LLS ALSO SUPPORTS HEALTH SERVICES RESEARCH WORKING TO IDENTIFY BARRIERS THAT PREVENT CERTAIN PATIENTS FROM BEING ABLE TO ACCESS THE TREATMENT AND CARE THAT THEY NEED AND FINDING ACTIONABLE SOLUTIONS THAT LLS CAN IMPLEMENT TO OVERCOME THESE BARRIERS AND ADVANCE ITS MISSION. TO DATE, LLS HAS INVESTED OVER $1.8 BILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. OUR SUSTAINED RESEARCH INVESTMENT OVER MULTIPLE DECADES HAS PAID OFF HANDSOMELY. THIS IS BEST DEMONSTRATED BY OUR SEMINAL INVESTMENT IN CHIMERIC ANTIGEN RECEPTOR T CELL (CAR T) THERAPY STARTING IN 1990 THAT, SINCE 2017, HAS TRANSLATED INTO 12 FDA-APPROVED CAR T THERAPIES FOR ACUTE B-CELL LEUKEMIA, NON-HODGKIN LYMPHOMA, AND MULTIPLE MYELOMA. CAR T THERAPY HAS IN SOME CASES PRODUCED CURES IN PATIENTS WHO HAVE FAILED ALL OTHER THERAPEUTIC OPTIONS.IN FISCAL YEAR 2024, LLS SUPPORTED RESEARCH IN THE U.S., CANADA AND 9 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF APPROXIMATELY $65.71 MILLION. RESEARCH FUNDING WAS DISTRIBUTED ACROSS ALL BLOOD CANCERS.IMPACT RESEARCH GRANTSTO ADDRESS UNEQUAL REPRESENTATION OF UNDERSERVED POPULATIONS IN CLINICAL TRIALS, IN 2021 WE ACTIVATED IMPACT (INFLUENTIAL MEDICINE PROVIDING ACCESS TO CLINICAL TRIALS) RESEARCH GRANTS. AN INITIAL FIVE-YEAR INVESTMENT OF $3.75 MILLION WAS ALLOCATED TO MAYO CLINIC, VANDERBILT UNIVERSITY MEDICAL CENTER, AND WEILL CORNELL MEDICINE IN NEW YORK CITY. WE NOW HAVE SIX IMPACT RESEARCH GRANTS IN PLACE SINCE OCTOBER 2022. THE IMPACT GRANTS WILL HELP THESE MAJOR CANCER CENTERS EXPAND CLINICAL TRIAL ACCESS TO LOCAL COMMUNITY-BASED HOSPITALS AND CLINICS WITH SUBSTANTIAL UNDERSERVED POPULATIONS. THE GOAL IS TO INCREASE TRIAL ENROLLMENT AMONG TRADITIONALLY UNDERSERVED POPULATIONS, INCLUDING RACIAL AND ETHNIC MINORITIES, RURAL RESIDENTS, AND INDIVIDUALS WITH LOW INCOME, THEREBY EXPANDING ACCESS TO STATE-OF-THE-ART THERAPIES TO A BROADER SWATH OF NEWLY DIAGNOSED BLOOD CANCER PATIENTS.EQUITY IN ACCESS RESEARCH PROGRAM IN 2022, LLS LAUNCHED THE EQUITY IN ACCESS RESEARCH PROGRAM, WHICH AIMS TO FUND RESEARCH THAT WILL GENERATE ACTIONABLE EVIDENCE TO ASSIST LLS IN ADVOCATING FOR CHANGES IN HEALTHCARE POLICY, DEVELOPING PATIENT-FACING PROGRAMS, AND FOSTERING PRACTICE CHANGE TO PROVIDE ALL PATIENTS WITH A FAIR AND JUST OPPORTUNITY TO SURVIVE WITH THE OPTIMAL QUALITY OF LIFE. SINCE INCEPTION OF THIS PROGRAM, LLS HAS AWARDED MORE THAN $5 MILLION TO PROJECTS ADDRESSING CRITICAL ISSUES SUCH AS THE COST OF ORAL ANTICANCER MEDICATIONS, ACCESS TO HEALTH INSURANCE, ACCESS TO SPECIALIZED CANCER CARE AMONG ADOLESCENTS AND YOUNG ADULTS, AND RACIAL DISPARITIES IN ACCESS TO HIGH-QUALITY END-OF-LIFE CARE. LLS RECOGNIZES THE CRITICAL NEED FOR EVIDENCE ON INTERVENTIONS TO INCREASE CANCER CLINICAL TRIAL PARTICIPATION, PARTICULARLY AMONG UNDERREPRESENTED GROUPS (I.E., ETHNIC AND RACIAL MINORITIZED GROUPS, INDIVIDUALS WITH LOW INCOME, OLDER ADULTS, AND PEOPLE WHO LIVE IN RURAL AREAS), AND WILL PRIORITIZE THIS RESEARCH THROUGH THE EQUITY IN ACCESS RESEARCH PROGRAM TO INCREASE ACCESS TO CLINICAL TRIALS, WHICH ARE CONSIDERED HIGH-QUALITY CANCER CARE. THERAPY ACCELERATION PROGRAM (TAP)TAP IS LLS' MISSION-DRIVEN, STRATEGIC VENTURE PHILANTHROPY INITIATIVE THAT SEEKS TO ACCELERATE THE DEVELOPMENT OF INNOVATIVE BLOOD CANCER THERAPEUTICS AND CHANGE THE STANDARD OF CARE. TAP COLLABORATES WITH BIOTECH COMPANIES TO SUPPORT THE DEVELOPMENT OF NOVEL PLATFORMS, FIRST-IN-CLASS ASSETS ADDRESSING UNMET MEDICAL NEEDS, EMERGING PATIENT POPULATIONS AND EVEN RARE BLOOD CANCERS.ESTABLISHED IN 2007, TAP HAS INVESTED MORE THAN $110 MILLION IN OVER 50 BIOTECH COMPANY PROJECTS. SINCE 2017, FIVE TAP-SUPPORTED THERAPIES HAVE BEEN APPROVED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) OR INCLUDED IN THE NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) GUIDELINES. CURRENTLY, THERE ARE OVER 30 ACTIVE CLINICAL STUDIES WITH TAP-SUPPORTED THERAPIES, INCLUDING SEVERAL REGISTRATION-ENABLING CLINICAL STUDIES IN BLOOD CANCER THAT COULD LEAD TO MORE FDA APPROVALS.BETWEEN JULY 2023 AND JUNE 2024 (FY24), TAP MADE INVESTMENTS IN FIVE BIOTECH COMPANIES THAT INCLUDED TWO EXISTING BIOTECH PARTNERS AND THREE BRAND NEW UP-AND-COMING BIOTECH COMPANIES, TO HELP THEM NAVIGATE THE DRUG DEVELOPMENT LANDSCAPE AND TO SUPPORT CLINICAL TRIALS FOR BLOOD CANCER PATIENTS. SEVERAL OF THESE COMPANIES ARE BASED IN EUROPE AND NOW, WITH HELP FROM TAP, THESE COMPANIES ARE RUNNING CLINICAL TRIALS IN THE US.NATIONAL PATIENT REGISTRY COVID INFORMATIONTHE ONGOING COVID-19 PANDEMIC ENGENDERED A HOST OF FEARS AND QUESTIONS FOR THE BLOOD CANCER COMMUNITY. WHEN PATIENT CONCERNS AROSE ABOUT WHETHER THE NEW VACCINES WOULD PROTECT THEM, LLS STEPPED IN TO FIND ANSWERS. IN FEBRUARY 2021, LLS ACTIVATED THE LLS NATIONAL PATIENT REGISTRY, A PROJECT SUPPORTED BY ETHEL AND BERNARD GARIL IN MEMORY OF THEIR SON, MICHAEL, WHO SUCCUMBED TO ACUTE LYMPHOBLASTIC LEUKEMIA. MORE THAN 9,000 BLOOD CANCER PATIENTS ANSWERED THE CALL TO JOIN THE REGISTRY AS "CITIZEN SCIENTISTS." THIS ALLOWED US TO GENERATE THE LARGEST DATA SET REPORTED TO DATE ON VACCINE SAFETY AND EFFICACY (INCLUDING BOOSTERS) ACROSS ALL MAJOR BLOOD CANCER AND TREATMENT TYPES. THIS INFORMATION HAS HELPED PATIENTS, HEALTHCARE PROVIDERS, AND PUBLIC HEALTH OFFICIALS MAKE MORE INFORMED CHOICES ABOUT COVID-19 PREVENTION.CLINICAL TRIALSBEAT AML MASTER TRIALBEGINNING NOVEMBER 2016, LLS LAUNCHED THE BEAT AML MASTER TRIAL, A COLLABORATIVE CLINICAL TRIAL TESTING SEVERAL NOVEL TARGETED THERAPIES FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) DESIGNED TO FACILITATE FDA APPROVAL OF NEW DRUGS AND CHANGE THE TREATMENT PARADIGM FOR PATIENTS DIAGNOSED WITH AML BY DEVELOPING MORE INDIVIDUALIZED, EFFECTIVE TREATMENT APPROACHES. THE MASTER TRIAL INVOLVES COLLABORATIONS WITH MULTIPLE MEDICAL INSTITUTIONS, DRUG COMPANIES, A GENOMIC PROVIDER, A CLINICAL RESEARCH ORGANIZATION, AND THE FDA, ALL OF WHOM HAVE COMMITTED TO WORKING COLLABORATIVELY. FROM INCEPTION THROUGH JUNE 2024, 491 PATIENTS PARTICIPATED IN CLINICAL TRIALS UNDER THE BEAT AML MASTER TRIAL.IN 2022, LLS LAUNCHED LLS' PEDIATRIC ACUTE LEUKEMIA (PEDAL) MASTER CLINICAL TRIAL. THIS UNPRECEDENTED INTERNATIONAL COLLOBORATION BETWEEN LLS, THE NATIONAL CANCER INSTITUTE (NCI), THE CHILDREN'S ONCOLOGY GROUP (OCG) AND OTHER PARTNERS BREAKS NEW GROUND, BRINGING PRECISION MEDICINE TO THE TREATMENT OF PEDIATRIC RELAPSED ACUTE LEUKEMIA. RATHER THAN A "ONE SIZE FITS ALL" APPROACH, PEDAL USES GENOMICS AND OTHER BIOMARKERS TO CUSTOMIZE TREATMENT, ALLOWING INNOVATIVE THERAPIES TO BE MATCHED TO PATIENTS BASED ON THEIR UNIQUE TUMOR BIOLOGY. A WIDE RANGE OF TRIAL SCREENIN LOCATIONS - SPANNING EUROPE, AUSTRALIA, NEW ZEALAND, CANADA, AND OVER 200 US SITES - ENSURES WIDESPREAD PARTICIPATION.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$104,363,302	ExpenseAmt
Grant	$55,112,788	GrantAmt
Desc	B) PATIENT & COMMUNITY SERVICES:AN ESTIMATED 1.7 MILLION PEOPLE ACROSS THE UNITED STATES (US) ARE CURRENTLY LIVING WITH OR ARE IN REMISSION FROM LEUKEMIA, LYMPHOMA AND MYELOMA. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) OFFERS AN ARRAY OF FREE, COMPREHENSIVE RESOURCES TO BLOOD CANCER PATIENTS, CAREGIVERS, FAMILIES AND FRIENDS OF PATIENTS, ADVOCATES, HEALTHCARE PROFESSIONALS AND THE PUBLIC. LLS IS COMMITTED TO PROVIDING THE MOST ACCURATE AND UP-TO-DATE BLOOD CANCER INFORMATION. PROFESSIONAL VOLUNTEER CLINICAL ADVISORS WORK WITH LLS STAFF TO REVIEW ALL OF THE INFORMATION LLS PROVIDES THROUGH HEALTHCARE PROFESSIONAL AND PATIENT EDUCATION PROGRAMS, PUBLICATIONS AND THE LLS WEBSITE. SUPPORT SERVICES ARE PROVIDED BY PROFESSIONALS OR RIGOROUSLY TRAINED PEER VOLUNTEERS. ALL RESOURCES ARE PROVIDED THROUGH A VARIETY OF MEDIA - PRINT, ONLINE, BY PHONE, AND FACE-TO-FACE IN COMMUNITIES. A NUMBER OF RESOURCES ARE AVAILABLE IN SPANISH FOR PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS.FINANCIAL ASSISTANCEOUR FINANCIAL ASSISTANCE PROGRAMS AIM TO LESSEN THE ECONOMIC TOLL ON PATIENTS AND FAMILIES TO HELP PATIENTS AFFORD LIFE-SAVING TREATMENTS. TO COUNTER CONTINUALLY RISING DRUG PRICES AND ALLEVIATE THE BURDENS FELT BY PATIENTS COPING WITH BLOOD CANCER, LLS PROVIDED 70,982 GRANTS TOTALING OVER $173M IN ASSISTANCE AWARDED. THE LION'S SHARE-OVER $158 MILLION- AWARDED TO SUPPORTED PATIENTS' INSURANCE PREMIUMS AND TREATMENT-RELATED CO-PAY AND CO-INSURANCE OUT OF POCKET COSTS THROUGH OUR CO-PAY ASSISTANCE PROGRAM.IN KEEPING WITH OUR COMMITMENT TO DIVERSITY, EQUITY, AND INCLUSION, LLS RECOGNIZES THAT NEED EXISTS THROUGHOUT ALL GEOGRAPHIC REGIONS AND WITHIN ALL PATIENT POPULATIONS, INCLUDING THOSE TRADITIONALLY UNDERREPRESENTED. CO-PAY ASSISTANCE PROGRAMTHE CO-PAY ASSISTANCE PROGRAM SUPPORTS QUALIFYING BLOOD CANCER PATIENTS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO- PAYMENT OBLIGATIONS RELATED TO TREATING THEIR BLOOD CANCER DIAGNOSIS. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUNDING AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. IN 2024, LLS AWARDED 29,605 GRANTS THROUGH ITS CO-PAY ASSISTANCE PROGRAM.SUSAN LANG PRE CAR T-CELL THERAPY TRAVEL ASSISTANCE PROGRAMLLS AWARDED 425 GRANTS EACH IN THE AMOUNT OF $2,500 FOR TREATMENT-RELATED TRANSPORTATION AND LODGING COSTS FOR PATIENTS WHO ARE BEING EVALUATED TO RECEIVE CAR T-CELL THERAPY AS EITHER STANDARD TREATMENT OR A CLINICAL TRIAL.SUSAN LANG PAY-IT-FORWARD PATIENT TRAVEL ASSISTANCE PROGRAMLLS AWARDED 2,079 GRANTS EACH IN THE AMOUNT OF $500 FOR TREATMENT-RELATED TRANSPORTATION AND LODGING COSTS.URGENT NEED PROGRAMIN PARTNERSHIP WITH MOPPIE'S LOVE AND CHARLIE'S FUND, LLS AWARDED 15,838 GRANTS EACH IN THE AMOUNT OF $500 FOR NON-MEDICAL LIVING EXPENSES-INCLUDING RENT, UTILITIES, AND FOOD.LOCAL FINANCIAL ASSISTANCE PROGRAM LLS AWARDED 4,339 GRANTS EACH IN THE AMOUNT OF $500 TO COVER NON-MEDICAL LIVING EXPENSES-INCLUDING RENT, UTILITIES, AND FOOD, ETC. PATIENT AID PROGRAM LLS AWARDED ONE-TIME STIPENDS OF $100 TO OVER 18,696 PATIENTS TO HELP OFFSET NON-MEDICAL EXPENSES. SCHOLARSHIP FOR BLOOD CANCER SURVIVORSIN 2024, THE LLS SCHOLARSHIP FOR BLOOD CANCER SURVIVORS AWARDED 236 SCHOLARSHIPS EACH UP TO $7,500 IN TUITION SUPPORT FOR VIRTUAL OR IN-PERSON VOCATIONAL, TWO-YEAR, ORFOUR-YEAR UNDERGRADUATE EDUCATION.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$23,265,032	ExpenseAmt
Desc	C) PUBLIC HEALTH EDUCATION:LLS BELIEVES KNOWLEDGE IS POWER. AS ALWAYS, LLS HAS OFFERED THEIR INFORMATIONAL PROGRAMS IN VIRTUAL FORMATS, CONTINUING TO PROVIDE VITALLY NEEDED EDUCATION AND EMOTIONAL SUPPORT FOR THOSE IMPACTED BY BLOOD CANCER. ONE-ON-ONE EDUCATION AND SUPPORTTRAINED ONCOLOGY INFORMATION SPECIALISTS IN OUR INFORMATION RESOURCE CENTER (IRC) PROVIDE PATIENTS AND CAREGIVERS WITH COMPASSIONATE, COMPREHENSIVE, AND TAILORED DISEASE AND TREATMENT INFORMATION, INCLUDING REFERRALS AND LINKS TO APPROPRIATE EDUCATIONAL RESOURCES AND LITERATURE; PSYCHOSOCIAL SUPPORT INFORMATION FOR ANY POINT IN THEIR TREATMENT JOURNEY; REFERRALS TO RELEVANT LOCAL, STATE AND/OR NATIONAL RESOURCES FOR ASSISTANCE; COVID-19 RELATED INFORMATION AND GUIDANCE; AND FINANCIAL RESOURCE INFORMATION TO COVER COSTS OF TREATMENT, TRAVEL, URGENT NEEDS AND MORE. OVER 25,000 INTERACTIONS BETWEEN THE IRC AND PATIENTS AND CAREGIVERS TOOK PLACE LAST YEAR.FACILITATING CLINICAL TRIAL ACCESSTHE LLS CLINICAL TRIAL SUPPORT CENTER (CTSC) GREW THROUGHOUT THE YEAR AS WE INCREASED OUR BI-LINGUAL AND PEDIATRIC EXPERTISE AMONG THE CTSC NURSE NAVIGATORS, AND CONTINUED TO EXPAND THE POSSIBILITY OF POSITIVE OUTCOMES FOR PATIENTS BY MATCHING THEM TO SUITABLE CLINICAL TRIALS. OUR NURSE NAVIGATORS ASSISTED 1077 PATIENTS. TWENTY PERCENT OF THESE PATIENTS ENTERED A TRIAL.OUTREACH TO UNDERSERVED GROUPSWE AUGMENTED EFFORTS TO EXPAND ACCESS TO LLS SERVICES AND RESOURCES BY BOLSTERING RELATIONS WITH COMMUNITY GROUPS AND LEADERS, NOTABLY IN THE BLACK AND LATINO COMMUNITIES, AND INCREASED OUR NUMBER OF BILINGUAL STAFF AND VOLUNTEERS. WE ALSO INCREASED ACCESSIBILITY OF OUR EDUCATION PROGRAMS TO RURAL PATIENTS AND FAMILIES VIA OUR VIRTUAL OFFERINGS. MOREOVER, WE EXPANDED PARTNERSHIPS WITH ADDITIONAL AFFINITY GROUPS INCLUDING: THE NATIONAL HISPANIC NURSES ASSOCIATION, NATIONAL ASSOCIATION OF COMMUNITY HEALTH WORKERS, THE LATINO CANCER INSTITUTE, NATIONAL BLACK NURSES ASSOCIATION, ALPHA PHI ALPHA.THE LLS MYELOMA LINK PROGRAM, LAUNCHED IN 2017, CONTINUED TO GAIN TRACTION. WE IMPROVED UNDERSTANDING OF TREATMENT OPTIONS BY PROVIDING IMPORTANT INFORMATION TO AFRICAN AMERICANS, WHO ARE TWICE AS LIKELY TO BE DIAGNOSED WITH MULTIPLE MYELOMA AS CAUCASIAN AMERICANS. IN 2024, LLS REACHED ALMOST 25,000 PEOPLE THROUGH MYELOMA LINK EDUCATION AND OUTREACH ACTIVITIES IN 15 CITIES ACROSS THE U.S.IN 2024, THE LLS LATINO OUTREACH PILOT REACHED APPROXIMATELY 100,000 SPANISH-SPEAKING COMMUNITY MEMBERS THROUGH COMMUNITY PROGRAMS ACROSS 5 MAJOR HISPANIC MARKETS (INCLUDING PR) AND OUR PARTNERSHIP WITH ENTRAVISION AND PRIME TIME INTERVIEWS WITH BOTH UNIVISION AND TELEMUNDO. EDUCATION AND PATIENT CONNECTIONSOUR VIRTUAL EDUCATION PROGRAMS PROVIDED BOTH PATIENTS AND FAMILIES, AS WELL AS HEALTH CARE PROFESSIONALS, ACCESS TO CONTENT INCLUDING BLOOD CANCER CONFERENCES, LOCAL EDUCATION PROGRAMS, NATIONAL WEBINARS, VIDEOS, LECTURES, AND PODCASTS.LLS'S HIGHLY VIEWED WEBSITE CONTINUES TO PROVIDE THE MOST UP TO DATE BLOOD CANCER INFORMATION INCLUDING ACCESS TO BLOGS, BOOKLETS, WORKBOOKS, FACT SHEETS AND MORE. IN ADDITION, 1,638 CANCER PATIENTS WERE PROVIDED WITH PERSONALIZED NUTRITION CONSULTATIONS BY LLS'S REGISTERED DIETITIANS. OUR PATIENT & COMMUNITY OUTREACH TEAM CONTINUED TO BRING PATIENTS TOGETHER VIA ONLINE LOCAL SUPPORT GROUPS AND CHATS. THE PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM MATCHED 2,200 PATIENTS WITH TRAINED VOLUNTEERS FACING THE SAME DISEASE.IN ADDITION, MEMBERSHIP IN LLS COMMUNITY-OUR ONLINE SOCIAL NETWORK- WAS 22,796, AN INCREASE OF 9% OVER FISCAL YEAR 2023.	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$16,017,073	ExpenseAmt
Desc	D) PROFESSIONAL EDUCATION:LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL DEPARTMENT OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT. UPCOMING AND ARCHIVED CE/CME PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/CE.IN FY 2024:-LLS PROVIDED 17 CME/CE-GRANTING LIVE EDUCATIONAL PROGRAMS, WITH 2,533 HEALTHCARE PROFESSIONALS IN ATTENDANCE. IN ADDITION 36 VIRTUAL LECTURES WERE PRESENTED WITH ALMOST 65,000 PARTICIPANTS.- OVER 22,000 PATIENTS AND PROFESSIONALS PARTICIPATED IN LIVE EDUCATION PROGRAMS DELIVERED VIRTUALLY AS WELL AS DELIVERED IN PERSON, LOCALLY AND REGIONALLY.-THERE WERE OVER 214,000 PAGE VIEWS FOR ARCHIVED WEB PROGRAMS, VIRTUAL LECTURES AND VIDEOS AND NEARLY 90,000 PODCAST DOWNLOADS. OVER 911,000 BOOKLETS AND FACT SHEETS WERE EITHER DOWNLOADED OR ORDERED IN HARD COPY.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$16,017,073	TotalOtherProgSrvcExpenseAmt
Total Program Service Expenses	$277,319,136	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	Yes (1)	CollectionsOfArtInd
Credit Counseling	Yes (1)	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (1)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (1)	ProfessionalFundraisingInd
Fundraising Activities	Yes (1)	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	Yes (1)	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	0	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (1)	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	Yes (1)	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (1)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	0	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	368	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	1228	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	0	UnrelatedBusIncmOverLimitInd
Foreign Financial Account	Yes (1)	ForeignFinancialAccountInd
Foreign Country	CA	ForeignCountryCd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (1)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (1)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	Yes (1)	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	20	GoverningBodyVotingMembersCnt
Independent Voting Member	20	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	Yes (1)	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	Yes (1)	LocalChaptersInd
Policies Reference Chapters	Yes (1)	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AZ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	DC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ID	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	LA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NE	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	GORDON MILLER JR	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	9148218935	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1201 15TH STREET NW SUITE 410	AddressLine1Txt
City	WASHINGTON	CityNm
State Abbreviation	DC	StateAbbreviationCd
ZIP	20005	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (31 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
JEFF SACHS
CHAIR	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
KATHLEEN MERIWETHER
VICE CHAIR	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
FREDA WANG
SECRETARY/TREASURER	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
JANICE GABRILOVE MD
AT LARGE	4.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
LEROY BALL
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RICHARD BAGGER
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
MARK BAEEENECHEA
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RENZO CANETTA MD
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
CASEY CUNNINGHAM MD
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
HELEN HESLOP
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
ARI MELNICK
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RUBEN MESA
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
LYNNE O'BRIEN
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
MARLA PERSKY
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
JIM REDDOCH
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
RICHARD RENDINA
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
ROBERT ROSEN
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
BART SICHEL
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
ALESSANDRA TOCCO
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
YVETTE TREMONTI
BOD MEMBER	4.00	0.00	Yes (X)		$0	$0	$0
E ANDERS KOLB - START 512023
PRESIDENT & CEO	40.00	0.00		Yes (X)	$471,613	$0	$8,226
GWEN NICHOLS
EVP, CHIEF MEDICAL OFC	40.00	0.00		Yes (X)	$526,284	$0	$50,687
TROY DUNMIRE
EVP, CHIEF OPERATING OFC	40.00	0.00		Yes (X)	$510,557	$0	$49,364
DALE NISSENBAUM
EVP, GENERAL COUNSEL	40.00	0.00		Yes (X)	$497,291	$0	$30,459
GORDON MILLER JR
EVP, CHIEF FINANCIAL OFC	40.00	0.00		Yes (X)	$453,172	$0	$58,818
COKER POWELL
SVP, CHIEF DEVELOPMENT OFC	40.00	0.00			$388,870	$0	$31,076	Yes (X)
VANESSA WHITE
SVP, CHIEF ADVANCEMENT OFC	40.00	0.00			$380,333	$0	$35,565	Yes (X)
SUSAN BROWN
SVP, CHIEF DEI OFC	40.00	0.00			$382,991	$0	$47,279	Yes (X)
LEE GREENBERGER
SVP, CHIEF SCIENTIFIC OFC	40.00	0.00			$377,058	$0	$45,160	Yes (X)
FLORENCE GODFREY
SVP, CHIEF EXPERIENCE OFC	40.00	0.00			$341,009	$0	$44,689	Yes (X)
LOUIS JDEGENNARO-END 63023
PRESIDENT & CEO - FORMER	40.00	0.00			$1,358,093	$0	$25,701		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$5,687,271	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$427,024	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	193	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (1)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
ICON PLC - PHARMACEUTICAL RESEARCH ASSOC
4130 PARKLAKE AVENUE SUITE 400	RALEIGH	NC	27612	CLINICAL TRIAL	$10,155,555
PATIENT ADVOCATE FOUNDATION
421 BUTLER FARM RD	HAMPTON	VA	23666	PAT ASSIST PROC	$7,679,383
SALESFORCE
140 E 45TH ST	NEW YORK	NY	10017	SOFTWARE	$3,860,428
RESOURCE ONE COMMUNICATIONS
2900 EAST APACHE STREET	TULSA	OK	74110	DIRECT MARKETING	$3,105,900
META PLATFORMS
1 HACKER WAY	MENLO PARK	CA	94025	ADVERTISING	$3,037,751

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	368	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$462,018	FederatedCampaignsAmt
Fundraising	$134,689,222	FundraisingAmt
All Other Contributions	$203,460,493	AllOtherContributionsAmt
Noncash Contributions	$3,270,884	NoncashContributionsAmt
Total Contributions	$338,611,733	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	SERVICE REVENUE	Desc
Business	810000	BusinessCd
Total Revenue Column	$14,932,514	TotalRevenueColumnAmt
Related Or Exempt Func Income	$14,932,514	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$14,932,514	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$14,243,283	TotalRevenueColumnAmt
Exclusion	$14,243,283	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,795,808	TotalRevenueColumnAmt
Exclusion	$3,795,808	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$180,888,282	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$178,507,683	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$2,380,599	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,380,599	TotalRevenueColumnAmt
Exclusion	$2,380,599	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$16,810,680	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$134,689,222	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$22,532,558	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$5,721,878	TotalRevenueColumnAmt
Exclusion	-$5,721,878	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$368,242,059	TotalRevenueColumnAmt
Related Or Exempt Func Income	$14,932,514	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$14,697,812	ExclusionAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part IX	Yes (X)	InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$52,558,533	TotalAmt
Program Services	$52,558,533	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$55,112,788	TotalAmt
Program Services	$55,112,788	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$11,802,743	TotalAmt
Program Services	$11,802,743	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$2,070,059	TotalAmt
Program Services	$878,840	ProgramServicesAmt
Management And General	$856,433	ManagementAndGeneralAmt
Fundraising	$334,786	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$107,937,447	TotalAmt
Program Services	$66,562,775	ProgramServicesAmt
Management And General	$22,886,622	ManagementAndGeneralAmt
Fundraising	$18,488,050	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$3,595,798	TotalAmt
Program Services	$2,191,206	ProgramServicesAmt
Management And General	$813,097	ManagementAndGeneralAmt
Fundraising	$591,495	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$16,388,463	TotalAmt
Program Services	$10,012,920	ProgramServicesAmt
Management And General	$3,667,835	ManagementAndGeneralAmt
Fundraising	$2,707,708	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$7,859,574	TotalAmt
Program Services	$4,789,465	ProgramServicesAmt
Management And General	$1,777,240	ManagementAndGeneralAmt
Fundraising	$1,292,869	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$2,731,853	TotalAmt
Program Services	$1,639,112	ProgramServicesAmt
Management And General	$737,600	ManagementAndGeneralAmt
Fundraising	$355,141	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$409,995	TotalAmt
Management And General	$409,995	ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$4,125,292	TotalAmt
Program Services	$4,125,292	ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$4,745,743	TotalAmt
Fundraising	$4,745,743	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$236,608	TotalAmt
Program Services	$180,162	ProgramServicesAmt
Management And General	$28,363	ManagementAndGeneralAmt
Fundraising	$28,083	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$21,893,141	TotalAmt
Program Services	$14,796,303	ProgramServicesAmt
Management And General	$3,927,127	ManagementAndGeneralAmt
Fundraising	$3,169,711	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$8,557,338	TotalAmt
Program Services	$5,515,795	ProgramServicesAmt
Management And General	$818,627	ManagementAndGeneralAmt
Fundraising	$2,222,916	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$14,860,478	TotalAmt
Program Services	$9,195,933	ProgramServicesAmt
Management And General	$1,336,863	ManagementAndGeneralAmt
Fundraising	$4,327,682	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$13,204,094	TotalAmt
Program Services	$995,589	ProgramServicesAmt
Management And General	$9,808,001	ManagementAndGeneralAmt
Fundraising	$2,400,504	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$3,897,493	TotalAmt
Program Services	$2,625,114	ProgramServicesAmt
Management And General	$625,947	ManagementAndGeneralAmt
Fundraising	$646,432	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$10,324,815	TotalAmt
Program Services	$7,868,519	ProgramServicesAmt
Management And General	$1,296,088	ManagementAndGeneralAmt
Fundraising	$1,160,208	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$5,425,197	TotalAmt
Program Services	$3,371,985	ProgramServicesAmt
Management And General	$1,169,149	ManagementAndGeneralAmt
Fundraising	$884,063	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$1,154,429	TotalAmt
Program Services	$710,625	ProgramServicesAmt
Management And General	$257,105	ManagementAndGeneralAmt
Fundraising	$186,699	FundraisingAmt

Other Expenses OtherExpensesGrp (2 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
RESEARCH & DEVELOPMENT	$18,281,905	$18,281,905
MISCELLANEOUS	$4,618,386	$4,103,532	-$141,814	$656,668

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$371,792,172	TotalAmt
Program Services	$277,319,136	ProgramServicesAmt
Management And General	$50,274,278	ManagementAndGeneralAmt
Fundraising	$44,198,758	FundraisingAmt

Field	Value	IRS element (for citing)
Joint Costs	Yes (X)	JointCostsInd

Total Joint Costs TotalJointCostsGrp

Field	Value	IRS element (for citing)
Total	$21,290,012	TotalAmt
Program Services	$13,907,952	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$7,382,060	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$1,093,408	BOYAmt
EOY	$3,858,985	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$87,996,059	BOYAmt
EOY	$143,907,675	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$29,923,480	BOYAmt
EOY	$45,469,673	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$5,045,849	BOYAmt
EOY	$5,836,452	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$31,315,227	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$20,562,994	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$13,251,184	BOYAmt
EOY	$10,752,233	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$463,285,795	BOYAmt
EOY	$353,960,098	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$20,291,527	BOYAmt
EOY	$22,812,891	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$10,015,427	BOYAmt
EOY	$11,136,057	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$516,667	BOYAmt
EOY	$316,667	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$12,472,475	BOYAmt
EOY	$3,959,788	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$643,891,871	BOYAmt
EOY	$602,010,519	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$21,647,040	BOYAmt
EOY	$36,559,192	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$219,704,797	BOYAmt
EOY	$155,633,120	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$15,561,185	BOYAmt
EOY	$14,667,950	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$14,425,281	BOYAmt
EOY	$4,198,076	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$271,338,303	BOYAmt
EOY	$211,058,338	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$281,881,454	BOYAmt
EOY	$251,301,743	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$90,672,114	BOYAmt
EOY	$139,650,438	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$372,553,568	BOYAmt
EOY	$390,952,181	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$643,891,871	BOYAmt
EOY	$602,010,519	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	-$3,550,113	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$21,613,526	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$335,200	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$427,419,530	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$441,317,494	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$400,540,019	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$357,670,634	CurrentTaxYearMinus1YearAmt
Current Tax Year	$338,611,733	CurrentTaxYearAmt
Total	$1,965,559,410	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$427,419,530	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$441,317,494	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$400,540,019	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$357,670,634	CurrentTaxYearMinus1YearAmt
Current Tax Year	$338,611,733	CurrentTaxYearAmt
Total	$1,965,559,410	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$553,410,745	SubstantialContributorsTotAmt
Public Support Total170	$1,412,148,665	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$29,082,073	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$16,877,123	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$18,087,763	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$13,066,416	CurrentTaxYearMinus1YearAmt
Current Tax Year	$18,039,091	CurrentTaxYearAmt
Total	$95,152,466	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$2,060,711,876	TotalSupportAmt
Gross Receipts Rltd Activities	$68,499,130	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.68530	PublicSupportCY170Pct
Public Support PY170	0.68950	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	Yes (1)	VolunteersInd
Paid Staff Or Management	Yes (1)	PaidStaffOrManagementInd
Media Advertisements	Yes (1)	MediaAdvertisementsInd
Media Advertisements	$1,087,778	MediaAdvertisementsAmt
Mailings Members	0	MailingsMembersInd
Publications Or Broadcast	Yes (1)	PublicationsOrBroadcastInd
Publications Or Broadcast	$1,029,920	PublicationsOrBroadcastAmt
Grants Other Organizations	0	GrantsOtherOrganizationsInd
Direct Contact Legislators	Yes (1)	DirectContactLegislatorsInd
Direct Contact Legislators	$763,999	DirectContactLegislatorsAmt
Rallies Demonstrations	Yes (1)	RalliesDemonstrationsInd
Rallies Demonstrations	$580,545	RalliesDemonstrationsAmt
Other Activities	Yes (1)	OtherActivitiesInd
Other Activities	$663,050	OtherActivitiesAmt
Total Lobbying Expenditures	$4,125,292	TotalLobbyingExpendituresAmt
Not Described Section501c3	0	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART II-B, LINE 1:	FormAndLineReferenceDesc
Explanation	LLS PARTICIPATES IN A NUMBER OF COALITIONS AND MEMBER ORGANIZATIONS, INCLUDING ALLIANCE FOR A STRONGER FDA, ALLIANCE FOR CHILDHOOD CANCER, ALLIANCE FOR FAIR HEALTHCARE PRICING, CANCER LEADERSHIP COUNCIL, DEFENSE HEALTH RESEARCH CONSORTIUM, MAPRX COALITION, NCSL FOUNDATION FOR STATE LEGISLATURES, ONE VOICE AGAINST CANCER, PARTNERSHIP TO PROTECT COVERAGE, PATIENT QUALITY OF LIFE COALITION, PUBLIC AFFAIRS COUNCIL, AND STATE ACCESS TO INNOVATIVE MEDICINES COALITION. EMPLOYEES IN THE LLS OFFICE OF PUBLIC POLICY WORK TO ADVANCE THE ORGANIZATION'S PUBLIC POLICY PRIORITIES, DOING SO WITH SUPPORT FROM LOBBYING FIRMS AND ADVISERS RETAINED BY LLS AND IN PARTNERSHIP WITH VOLUNTEER ADVOCATES. LLS VOLUNTEER ADVOCATES ENGAGE THEIR LAWMAKERS BY CONDUCTING LETTER-WRITING CAMPAIGNS, SHARING THEIR PERSONAL STORIES, AND CONDUCTING ONE-ON-ONE VISITS IN STATE CAPITOLS AND IN WASHINGTON, D.C. ALL WITH SUPPORT FROM THE LLS OFFICE OF PUBLIC POLICY.	ExplanationTxt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Solicited Assets Sale	0	SolicitedAssetsSaleInd
Agent Trustee Etc	Yes (1)	AgentTrusteeEtcInd
Beginning Balance	$0	BeginningBalanceAmt
Additions During Year	$1,000,000	AdditionsDuringYearAmt
Ending Balance	$1,000,000	EndingBalanceAmt
Incl Escrow Custodial Acct Liab	Yes (1)	InclEscrowCustodialAcctLiabInd

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,730,391	BeginningYearBalanceAmt
Contributions	$80,666	ContributionsAmt
Investment Earnings Or Losses	$787,363	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$308,062	GrantsOrScholarshipsAmt
Administrative Expenses	$13,050	AdministrativeExpensesAmt
End Year Balance	$8,277,308	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,288,293	BeginningYearBalanceAmt
Contributions	$30,000	ContributionsAmt
Investment Earnings Or Losses	$713,739	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$291,598	GrantsOrScholarshipsAmt
Administrative Expenses	$10,043	AdministrativeExpensesAmt
End Year Balance	$7,730,391	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$7,381,460	BeginningYearBalanceAmt
Contributions	$1,129,903	ContributionsAmt
Investment Earnings Or Losses	-$913,685	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$295,324	GrantsOrScholarshipsAmt
Administrative Expenses	$14,061	AdministrativeExpensesAmt
End Year Balance	$7,288,293	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$5,902,791	BeginningYearBalanceAmt
Contributions	$1,650	ContributionsAmt
Investment Earnings Or Losses	$1,726,314	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$236,177	GrantsOrScholarshipsAmt
Administrative Expenses	$13,118	AdministrativeExpensesAmt
End Year Balance	$7,381,460	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$6,168,319	BeginningYearBalanceAmt
Investment Earnings Or Losses	-$8,812	InvestmentEarningsOrLossesAmt
Grants Or Scholarships	$246,718	GrantsOrScholarshipsAmt
Administrative Expenses	$9,998	AdministrativeExpensesAmt
End Year Balance	$5,902,791	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Prmnnt Endowment Balance EOY	0.60190	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.39810	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,038,869	OtherCostOrOtherBasisAmt
Depreciation	$945,434	DepreciationAmt
Book Value	$93,435	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$30,224,812	OtherCostOrOtherBasisAmt
Depreciation	$19,566,014	DepreciationAmt
Book Value	$10,658,798	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$51,546	OtherCostOrOtherBasisAmt
Depreciation	$51,546	DepreciationAmt
Book Value	$0	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$10,752,233	TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

Field	Value	IRS element (for citing)
Desc	CAPITAL LEASE LIABILITY	Desc
Amt	$4,198,076	Amt

Field	Value	IRS element (for citing)
Total Liability	$4,198,076	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$388,210,511	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$2,380,597	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$12,063,656	DonatedServicesAndUseFcltsAmt
Other Revenue	$10,522,001	OtherRevenueAmt
Revenue Not Reported	$20,205,060	RevenueNotReportedAmt
Revenue Subtotal	$368,005,451	RevenueSubtotalAmt
Investment Expenses Not Incld	$236,608	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$236,608	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$368,242,059	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$394,745,114	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$12,063,656	DonatedServicesUseFcltsAmt
Other Expenses Included	$11,125,894	OtherExpensesIncludedAmt
Expenses Not Reported	$23,189,550	ExpensesNotReportedAmt
Expenses Subtotal	$371,555,564	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$236,608	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$236,608	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$371,792,172	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART III, LINE 1A:	THE LLS COLLECTION IS OF PHOTOGRAPHS WHICH ARE USED FOR PUBLIC EXHIBITION AT FUNDRAISING EVENTS HELD TO SUPPORT LLS'S PROGRAMS.
PART IV, LINE 1B:	LLS HELD $1 MILLION IN ESCROW ON BEHALF OF IFLI AS PART OF A PASS-THROUGH GRANT AGREEMENT.
PART V, LINE 4:	LLS'S ENDOWMENTS ARE INTENDED TO FUND RESEARCH AS WELL AS SUPPORT LLS'S PUBLIC EDUCATION PROGRAMS.
PART X, LINE 2:	LLS, LLSRP, AND LLSRF QUALIFY AS CHARITABLE ORGANIZATIONS AS DEFINED BY INTERNAL REVENUE CODE SECTION 501(C)(3) AND, ACCORDINGLY, ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER INTERNAL REVENUE CODE SECTION 501(A). ADDITIONALLY, SINCE THESE ORGANIZATIONS ARE PUBLICLY SUPPORTED, CONTRIBUTIONS QUALIFY FOR THE MAXIMUM CHARITABLE CONTRIBUTION DEDUCTION UNDER THE INTERNAL REVENUE CODE. LLSC IS REGISTERED AS A CHARITABLE ORGANIZATION UNDER THE INCOME TAX ACT (CANADA) AND IS, THEREFORE, NOT SUBJECT TO INCOME TAXES IF CERTAIN DISBURSEMENT REQUIREMENTS ARE MET. LLS AND ITS RELATED ENTITIES RECOGNIZE THE EFFECT OF TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO LLS'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. THERE WERE NO ENTITIES THAT RECOGNIZED UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED JUNE 30, 2024 AND JUNE 30, 2023.
PART XI, LINE 2D - OTHER ADJUSTMENTS:	LLS CANADA REVENUE 10,522,001.
PART XII, LINE 2D - OTHER ADJUSTMENTS:	LLS CANADA EXPENSE 11,125,894.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (5 entries)

RegionRegionTxt	OfficesOfficesCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA	1	RESEARCH FUNDING	RESEARCH GRANTS	$1,503,560
EUROPE		RESEARCH FUNDING	RESEARCH GRANTS	$7,930,983
CENTRAL AMERICA & CARIBBEAN		INVESTMENTS	INVESTMENTS	$9,358,822
EAST ASIA & THE PACIFIC		RESEARCH FUNDING	RESEARCH GRANTS	$2,368,200
EUROPE		INVESTMENTS	INVESTMENTS	$8,036,661

Field	Value	IRS element (for citing)
Subtotal Offices	1	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	1	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$29,198,226	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$29,198,226	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (28 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$249,656	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$249,500	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$249,975	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$249,069	WIRE PAYMENT	$0	ACCRUAL
EAST ASIA & THE PACIFIC	RESEARCH GRANTS	$120,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$125,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$150,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$150,000	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$78,600	WIRE PAYMENT	$0	ACCRUAL
NORTH AMERICA	RESEARCH GRANTS	$999,960	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$31,667	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$750,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$496,337	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$125,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$50,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$249,977	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$250,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$231,171	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$1,700,000	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$425,841	WIRE PAYMENT	$0	ACCRUAL
EUROPE	RESEARCH GRANTS	$186,861	WIRE PAYMENT	$0	ACCRUAL
EUROPE	THERAPY ACCELERATION	$3,181,189	WIRE PAYMENT	$0	FMV

Field	Value	IRS element (for citing)
Total501c3 Org	0	Total501c3OrgCnt
Total Other Org	29	TotalOtherOrgCnt
Transfer To Foreign Corp	Yes (1)	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	Yes (1)	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	Yes (1)	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. THE ACCOUNTING METHOD UTILIZED FOR GRANTS REPORTED ON PART II IS THE ACCRUAL METHOD AS CONSISTENT WITH BOOKS AND RECORDS.	ExplanationTxt

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (1)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd	Gross ReceiptsGrossReceiptsAmt	Retained By ContractorRetainedByContractorAmt	Net To OrganizationNetToOrganizationAmt
THOMPSON HABIB & DENISON
80 HAYDEN AVENUE SUITE 300	LEXINGTON	MA	02421	DIRECT MAIL	0	$0	$413,042	-$413,042
RESOURCE ONE
2900 EAST APACHE STREET	TULSA	OK	74110	DIRECT MAIL	0	$0	$3,105,900	-$3,105,900

Field	Value	IRS element (for citing)
Total Retained By Contractors	$3,518,942	TotalRetainedByContractorsAmt
Total Net To Organization	-$3,518,942	TotalNetToOrganizationAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DE	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	ID	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	IN	LicensedStatesCd
Licensed States	IA	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	MT	LicensedStatesCd
Licensed States	NE	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	SD	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	TX	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd
Licensed States	WY	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	PR	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	LAKE TAHOE BIKE RIDE	Event1Nm
Gross Receipts Event1	$2,840,907	GrossReceiptsEvent1Amt
Charitable Contri Event1	$2,354,726	CharitableContriEvent1Amt
Gross Revenue Event1	$486,181	GrossRevenueEvent1Amt
Non Cash Prizes Event1	$86,656	NonCashPrizesEvent1Amt
Rent Facility Costs Event1	$226,676	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$73,728	FoodAndBeverageEvent1Amt
Entertainment Event1	$103,761	EntertainmentEvent1Amt
Other Direct Expenses Event1	$99,687	OtherDirectExpensesEvent1Amt
Event2	HOUSTON STUDENT VISIONARIES	Event2Nm
Gross Receipts Event2	$2,803,106	GrossReceiptsEvent2Amt
Charitable Contri Event2	$2,672,567	CharitableContriEvent2Amt
Gross Revenue Event2	$130,539	GrossRevenueEvent2Amt
Non Cash Prizes Event2	$23,792	NonCashPrizesEvent2Amt
Rent Facility Costs Event2	$39,331	RentFacilityCostsEvent2Amt
Food And Beverage Event2	$88,948	FoodAndBeverageEvent2Amt
Entertainment Event2	$8,170	EntertainmentEvent2Amt
Other Direct Expenses Event2	$1,750	OtherDirectExpensesEvent2Amt
Other Events Total	260	OtherEventsTotalCnt
Gross Receipts Other Events	$145,855,889	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$129,661,929	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$16,193,960	GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events	$2,185,838	NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events	$13,808,655	RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events	$3,386,465	FoodAndBeverageOtherEventsAmt
Entertainment Other Events	$1,695,286	EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events	$703,815	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$151,499,902	GrossReceiptsTotalAmt
Charitable Contributions Tot	$134,689,222	CharitableContributionsTotAmt
Gross Revenue Total Events	$16,810,680	GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events	$2,296,286	NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events	$14,074,662	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$3,549,141	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$1,807,217	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$805,252	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$22,532,558	DirectExpenseSummaryEventsAmt
Net Income Summary	-$5,721,878	NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE G, PART I, LINE 2B, COLUMN (V)	FormAndLineReferenceDesc
Explanation	LLS USED RESOURCE ONE AND THOMPSON HABIB, & DENISON FOR IT'S NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMS.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (69 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
COLUMBIA UNIVERSITY MEDICAL CENTER
535 W 116TH ST	NEW YORK	NY	10027	135598093	501(C)(3)	$1,200,000	$0	ACCRUAL	RESEARCH GRANT
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVE BELFER 1108	BRONX	NY	10461	472209056	501(C)(3)	$1,189,743	$0	ACCRUAL	RESEARCH GRANT
ATRIUM HEALTH FOUNDATION
7800 PROVIDENCE RD	CHARLOTTE	NC	28226	566060481	501(C)(3)	$124,866	$0	ACCRUAL	RESEARCH GRANT
BAYLOR COLLEGE OF MEDICINE
PO BOX 301207	DALLAS	TX	75303	741613878	501(C)(3)	$222,716	$0	ACCRUAL	RESEARCH GRANT
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 EAST DUARTE ROAD	DUARTE	CA	91010	953432210	501(C)(3)	$806,250	$0	ACCRUAL	RESEARCH GRANT
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413	BOSTON	MA	02241	042774441	501(C)(3)	$500,000	$0	ACCRUAL	RESEARCH GRANT
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINATTI	OH	45229	310833936	501(C)(3)	$840,000	$0	ACCRUAL	RESEARCH GRANT
CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUE	CLEVELAND	OH	44195	340714585	501(C)(3)	$150,000	$0	ACCRUAL	RESEARCH GRANT
DANA-FARBER CANCER INSTITUTE INC
450 BROOKLINE AVENUE	BOSTON	MA	02215	042263040	501(C)(3)	$4,743,450	$0	ACCRUAL	RESEARCH GRANT
DREN BIO
384 FOSTER CITY BLVD	FOSTER CITY	CA	94404	841826535		$3,200,000	$0	FMV	THERAPY ACCELERATION
DUKE UNIVERSITY MEDICAL CENTER
PO BOX 602651	CHARLOTTE	NC	28260	560532129	501(C)(3)	$194,977	$0	ACCRUAL	RESEARCH GRANT
EMORY UNIVERSITY
PO BOX 935084	ATLANTA	GA	31193	582137993	501(C)(3)	$1,591,088	$0	ACCRUAL	RESEARCH GRANT
FRED HUTCHINSON CANCER CENTER
1100 FAIRVIEW AVENUE NORTH	SEATTLE	WA	98109	237156071	501(C)(3)	$1,438,989	$0	ACCRUAL	RESEARCH GRANT
GEORGE WASHINGTON UNIVERSITY
2121 I ST NW	WASHINGTON	DC	20052	530196584	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
PO BOX 742801	ATLANTA	GA	30374	593238634	501(C)(3)	$2,062,118	$0	ACCRUAL	RESEARCH GRANT
HOUSTON METHODIST RESEARCH INSTITUTE
6670 BERTNER AVENUE	HOUSTON	TX	77030	870721923	501(C)(3)	$500,000	$0	ACCRUAL	RESEARCH GRANT
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
ONE GUSTAVE L LEVY PLACE	NEW YORK	NY	10029	136171197	501(C)(3)	$577,750	$0	ACCRUAL	RESEARCH GRANT
IMMUNITAS THERAPEUTICS INC
21 HICKORY DR	WALTHAM	MA	02451	842813217		$95,605	$0	ACCRUAL	RESEARCH GRANT
INDIANA UNIVERSITY
2101 E COLISEUM BLVD	FORT WAYNE	IN	46805	356001673	501(C)(3)	$546,000	$0	ACCRUAL	RESEARCH GRANT
INTERNATIONAL WALDENSTROM'S MACROGLOBULINEMIA FOUNDATION
6144 CLARK CENTER AVE	SARASOTA	FL	34238	541784426	501(C)(3)	$50,000	$0	ACCRUAL	RESEARCH GRANT
JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
575 LEXINGTON AVE	NEW YORK	NY	10022	131623978	501(C)(3)	$2,365,000	$0	ACCRUAL	RESEARCH GRANT
MAINE MEDICAL CENTER
22 BRAMHALL STREET	PORTLAND	ME	04102	010238552	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
MASSACHUSETTS GENERAL HOSPITAL
PO BOX 414876	BOSTON	MA	02241	041564655	501(C)(3)	$1,000,000	$0	ACCRUAL	RESEARCH GRANT
MAYO CLINIC ROCHESTER
PO BOX 860334	MINNEAPOLIS	MN	55486	416011702	501(C)(3)	$275,000	$0	ACCRUAL	RESEARCH GRANT
MPN RESEARCH
PO BOX 10743	CHICAGP	IL	60610	364330967	501(C)(3)	$50,000	$0	FMV	THERAPY ACCELERATION
MYELOPROLIFERATIVE NEOPLASMS RESEARCH FOUNDATION
PO BOX 2690	CAROL STREAM	IL	60601	364330967	501(C)(3)	$100,000	$0	ACCRUAL	RESEARCH GRANT
NORTHWESTERN UNIVERSITY
633 CLARK AVE	EVANSTON	IL	60208	362167817	501(C)(3)	$598,047	$0	ACCRUAL	RESEARCH GRANT
NYU GROSSMAN SCHOOL OF MEDICINE
550 FIRST AVENUE	NEW YORK	NY	10016	135562308	501(C)(3)	$245,940	$0	ACCRUAL	RESEARCH GRANT
OREGON HEALTH & SCIENCE UNIVERSITY CANCER INSTITUTE
3181 SW SAM JACKSON PARK ROAD	PORTLAND	OR	97239	237083114	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
OSU FOUNDATION
1960 KENNY ROAD 4TH FLOOR	COLUMBUS	OH	43210	316025986	GOVT	$546,652	$0	ACCRUAL	RESEARCH GRANT
PERELMAN SCHOOL OF MEDICINE AT THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREET FRANKLIN BLDG	PHILADELPHIA	PA	19104	231352685	501(C)(3)	$950,000	$0	ACCRUAL	RESEARCH GRANT	P-221
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
MASSACHUSETTS HALL	CAMBRIDGE	MA	02138	042103580	501(C)(3)	$100,000	$0	ACCRUAL	RESEARCH GRANT
REGENTS OF THE UNIVERSITY OF MICHIGAN
PO BOX 223131	PITTSBURGH	PA	15251	386006309	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
RHODE ISLAND HOSPITAL
593 EDDY STREET	PROVIDENCE	RI	02903	050258954	501(C)(3)	$125,000	$0	ACCRUAL	RESEARCH GRANT
RUTGERS UNIVERSITY
3 RUTGERS PLAZA	NEW BRUNSWICK	NJ	08901	226001086	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NE	SEATTLE	WA	98105	911156519	501(C)(3)	$31,250	$0	ACCRUAL	RESEARCH GRANT
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH
PO BOX 026338	NEW YORK	NY	10087	131924236	501(C)(3)	$2,237,344	$0	ACCRUAL	RESEARCH GRANT
ST JUDE CHILDREN'S RESEARCH HOSPITAL
PO BOX 1000 DEPT 949	MEMPHIS	TN	38148	620646012	501(C)(3)	$1,326,339	$0	ACCRUAL	RESEARCH GRANT
TEXAS A&M UNIVERSITY HEALTH SCIENCE CENTER
8441 RIVERSIDE PKWY	BRYAN	TX	77807	742907553	GOVT	$312,500	$0	ACCRUAL	RESEARCH GRANT
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
450 SERRA MALL	STANFORD	CA	94305	941156365	501(C)(3)	$2,452,718	$0	ACCRUAL	RESEARCH GRANT
THE BRIGHAM AND WOMENS HOSPITAL INC
PO BOX 3149	BOSTON	MA	02241	042312909	501(C)(3)	$135,000	$0	ACCRUAL	RESEARCH GRANT
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
PO BOX 8500	PHILADELPHIA	PA	19178	231352166	501(C)(3)	$315,000	$0	ACCRUAL	RESEARCH GRANT
THE JACKSON LABORATORY
600 MAIN STREET	BAR HARBOR	ME	04609	010211513	501(C)(3)	$130,000	$0	ACCRUAL	RESEARCH GRANT
THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
12529 COLLECTIONS CENTER DRIVE	CHICAGO	IL	60693	520595110	501(C)(3)	$250,000	$0	ACCRUAL	RESEARCH GRANT
THE MEDICAL COLLEGE OF WISCONSIN INC
8701 W WATERTOWN PLANK RD	MILWAUKEE	WI	53226	390806261	501(C)(3)	$375,000	$0	ACCRUAL	RESEARCH GRANT
THE OHIO STATE UNIVERSITY
1960 KENNY ROAD 4TH FLOOR	COLUMBUS	OH	43210	316025986	501(C)(3)	$328,124	$0	ACCRUAL	RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE MC 0009	LA JOLLA	CA	92093	956006144	501(C)(3)	$690,000	$0	ACCRUAL	RESEARCH GRANT
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
1855 FOLSOM ST	SAN FRANCISCO	CA	94103	946036493	501(C)(3)	$875,000	$0	ACCRUAL	RESEARCH GRANT
THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER
333 COTTMAN AVENUE	PHILADELPHIA	PA	19111	232003072	501(C)(3)	$599,926	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVENUE SOUTH SUITE 1170 AB	BIRMINGHAM	AL	35294	636005396	GOVT	$625,000	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF CHICAGO
5841 S MARYLAND AVE MC6092	CHICAGO	IL	60637	362177139	501(C)(3)	$187,000	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF TEXAS AT AUSTIN
101 E 27TH ST	AUSTIN	TX	78712	746000203	GOVT	$250,000	$0	ACCRUAL	RESEARCH GRANT
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
PO BOX 4266	HOUSTON	TX	77210	746001118	GOVT	$2,453,448	$0	ACCRUAL	RESEARCH GRANT
TUFTS MEDICAL CENTER
800 WASHINGTON STREET 453	BOSTON	MA	02111	042103634	501(C)(3)	$232,605	$0	ACCRUAL	RESEARCH GRANT
UNC LINEBERGER COMPREHENSIVE CANCER CENTER
104 AIRPORT DRIVE	CHAPEL HILL	NC	27599	566001393	501(C)(3)	$70,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
4301 WEST MARKHAM ST	LITTLE ROCK	AR	72205	716046242	GOVT	$250,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF COLORADO DENVER ANSCHUTZ MEDICAL CAMPUS
PO BOX 6508	AURORA	CO	80045	846000555	501(C)(3)	$1,590,000	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF FLORIDA
33 TIGERT HALL	GAINESVILLE	FL	32611	596002052	501(C)(3)	$2,210,588	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF MIAMI
PO BOX 405803	ATLANTA	GA	30384	590624458	501(C)(3)	$1,074,768	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF PENNSYLVANIA DEPARTMENT OF MEDICINE
3451 WALNUT STREET FRANKLIN BLDG	PHILADELPHIA	PA	19104	231352685	501(C)(3)	$749,214	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF PITTSBURGH
4200 FIFTH AVE	PITTSBURGH	PA	15260	250965591	501(C)(3)	$74,475	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF SOUTHERN CALIFORNIA
700 CHILDS WAY	LOS ANGELES	CA	90089	951642394	501(C)(3)	$239,560	$0	ACCRUAL	RESEARCH GRANT
UNIVERSITY OF VIRGINIA
PO BOX 400195	CHARLOTTESVILLE	VA	22904	237173411	501(C)(3)	$999,997	$0	ACCRUAL	RESEARCH GRANT
VAN ANDEL RESEARCH INSTITUTE
333 BOSTWICK AVE NE	GRAND RAPIDS	MI	49503	522000820	501(C)(3)	$120,000	$0	ACCRUAL	RESEARCH GRANT
VANDERBILT UNIVERSITY MEDICAL CENTER
PO BOX 121236	DALLAS	TX	75312	620476822	501(C)(3)	$371,000	$0	ACCRUAL	RESEARCH GRANT
VERSITI BLOOD CENTER OF WISCONSIN
638 N 18TH ST	MILWAUKEE	WI	53233	390807235	501(C)(3)	$37,500	$0	ACCRUAL	RESEARCH GRANT
VITTORIA BIOTHERAPEUTICS
3675 MARKET STREET	PHILADELPHOA	PA	19104	863850050		$500,000	$0	ACCRUAL	RESEARCH GRANT
WASHINGTON UNIVERSITY IN ST LOUIS
700 ROSEDALE AVENUE	ST LOUIS	MO	63112	430653611	501(C)(3)	$2,583,235	$0	ACCRUAL	RESEARCH GRANT
YALE UNIVERSITY
PO BOX 1873	NEW HAVEN	CT	06520	060646973	501(C)(3)	$325,000	$0	ACCRUAL	RESEARCH GRANT

Field	Value	IRS element (for citing)
Total501c3 Org	66	Total501c3OrgCnt
Total Other Org	3	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (10 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt
COPAY ASSISTANCE CLL	9903	$25,992,224
COPAY ASSISTANCE LYMPHOMA	4960	$12,367,827
COPAY ASSISTANCE MDS	1225	$0
COPAY ASSISTANCE MYELOMA	7518	$0
COPAY ASSISTANCE MANTEL	149	$0
COPAY ASSISTANCE WALDENST	415	$1,697,709
COPAY ASSISTANCE ALL	76	$379,947
COPAY ASSISTANCE AML	5359	$10,987,710
PATIENT TRAVEL ASSISTANCE	3304	$1,160,225
PATIENT AID	55805	$13,358,106

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. PATIENT FINANCIAL AID: THE LEUKEMIA AND LYMPHOMA SOCIETY (LLS) REGULARLY RECEIVES CALLS FROM PATIENTS WHO CANNOT MOVE FORWARD WITH THEIR POTENTIALLY LIFE-SAVING TREATMENTS BECAUSE THEY CANNOT AFFORD TO PAY FOR MANY EXPENSES RELATED TO THEIR TREATMENT. SOMETIMES PATIENTS HAVE TO CHOOSE BETWEEN BASIC NEEDS SUCH AS FOOD OR SHELTER AND THEIR HEALTH CARE TREATMENT EXPENSES. IN AN EFFORT TO ALLEVIATE SUCH HARDSHIPS, LLS HAS ESTABLISHED A PATIENT FINANCIAL AID PROGRAM THAT PROVIDES APPLICANTS, WHO RESIDE IN THE US AND HAVE A BLOOD CANCER DIAGNOSIS, A ONE-TIME ANNUAL STIPEND OF HELP DEFER SOME OF THESE EXPENSES. LLS ROUTINELY CONDUCTS AN OPERATIONAL AUDIT VERIFYING APPLICANTS ARE IN COMPLIANCE WITH PROGRAM GUIDELINES AND PROGRAM CRITERIA. CO-PAY ASSISTANCE: PATIENT APPLICATIONS ARE PROCESSED ON A FIRST COME, FIRST SERVED BASIS. ELIGIBLE PATIENTS MUST RESIDE IN THE UNITED STATES OR PUERTO RICO, HAVE A PROGRAM COVERED BLOOD CANCER DIAGNOSIS CONFIRMED BY A PHYSICIAN, MAINTAIN MEDICAL/PRESCRIPTION INSURANCE AND HAVE HOUSEHOLD INCOME AT OR BELOW 500% OF THE US FEDERAL POVERTY LEVEL AS ADJUSTED BY HOUSEHOLD SIZE AND COST OF LIVING INDEX. PATIENTS MUST PROVIDE PROOF OF INSURANCE AND INCOME. QUALIFYING PATIENTS ARE APPROVED FOR A TWELVE MONTH COVERAGE PERIOD. PATIENT TRAVEL ASSISTANCE: THE LEUKEMIA AND LYMPHOMA SOCIETY (LLS) REGULARLY RECEIVES CALLS FROM PATIENTS WHO CANNOT MOVE FORWARD WITH THEIR POTENTIALLY LIFE-SAVING TREATMENTS BECAUSE THEY CANNOT AFFORD TO PAY FOR TRANSPORTATION TO GET TO THEIR PROVIDERS, E.G. DOCTORS, HOSPITALS, TRANSPLANT CENTERS, AND RESEARCH OR CLINICAL TRIAL CENTERS. SOMETIMES PATIENTS HAVE TO TRAVEL OUT-OF-STATE TO GET THEIR PRESCRIBED AND RECOMMENDED TREATMENTS, OFTEN TIMES RESULTING IN PATIENTS HAVING TO CHOOSE BETWEEN BASIC NEEDS SUCH AS FOOD OR SHELTER AND THEIR HEALTH CARE. IN AN EFFORT TO ALLEVIATE SUCH HARDSHIPS, LLS ESTABLISHED THE TRAVEL ASSISTANCE PROGRAM WHICH PROVIDES APPLICANTS, WHO ARE US CITIZENS OR PERMANENT RESIDENTS, HAVE AN ANNUAL INCOME AT OR BELOW 500% OF THE FEDERAL POVERTY LEVEL (FPL) AND HAVE A CONFIRMED BLOOD CANCER DIAGNOSIS, A ONE-TIME ANNUAL STIPEND TO HELP DEFER SOME OF THESE EXPENSES. LLS ROUTINELY CONDUCTS AN OPERATIONAL AUDIT VERIFYING APPLICANTS ARE IN COMPLIANCE WITH PROGRAM GUIDELINES AND PROGRAM CRITERIA.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (1)	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
LOUIS JDEGENNARO-END 63023
PRESIDENT & CEO - FORMER	$380,343	$0	$970,000	$0	$7,750	$0	$20,790	$0	$4,911	$0	$1,383,794	$0	$0	$0
GWEN NICHOLS
EVP, CHIEF MEDICAL OFC	$440,830	$0	$50,000	$0	$35,454	$0	$16,500	$0	$34,187	$0	$576,971	$0	$0	$0
TROY DUNMIRE
EVP, CHIEF OPERATING OFC	$459,027	$0	$50,000	$0	$1,530	$0	$11,550	$0	$37,814	$0	$559,921	$0	$0	$0
DALE NISSENBAUM
EVP, GENERAL COUNSEL	$442,974	$0	$50,000	$0	$4,317	$0	$11,550	$0	$18,909	$0	$527,750	$0	$0	$0
GORDON MILLER JR
EVP, CHIEF FINANCIAL OFC	$401,060	$0	$50,000	$0	$2,112	$0	$16,500	$0	$42,318	$0	$511,990	$0	$0	$0
E ANDERS KOLB - START 512023
PRESIDENT & CEO	$470,244	$0	$0	$0	$1,369	$0	$0	$0	$8,226	$0	$479,839	$0	$0	$0
SUSAN BROWN
SVP, CHIEF DEI OFC	$379,359	$0	$0	$0	$3,632	$0	$16,500	$0	$30,779	$0	$430,270	$0	$0	$0
LEE GREENBERGER
SVP, CHIEF SCIENTIFIC OFC	$346,994	$0	$20,000	$0	$10,064	$0	$11,550	$0	$33,610	$0	$422,218	$0	$0	$0
COKER POWELL
SVP, CHIEF DEVELOPMENT OFC	$365,009	$0	$0	$0	$23,861	$0	$11,550	$0	$19,526	$0	$419,946	$0	$0	$0
VANESSA WHITE
SVP, CHIEF ADVANCEMENT OFC	$379,032	$0	$0	$0	$1,301	$0	$11,550	$0	$24,015	$0	$415,898	$0	$0	$0
FLORENCE GODFREY
SVP, CHIEF EXPERIENCE OFC	$336,016	$0	$0	$0	$4,993	$0	$16,019	$0	$28,670	$0	$385,698	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 7	FormAndLineReferenceDesc
Explanation	LLS AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEE PERFORMANCE AND ORGANIZATION TARGETS. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2,PART II, COL (B) (II).	ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	193	ContributionCnt
Noncash Contributions Rpt F990	$3,141,651	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FAIR MARKET VALUE	MethodOfDeterminingRevenuesTxt

Food Inventory FoodInventoryGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	9	ContributionCnt
Noncash Contributions Rpt F990	$67,424	NoncashContributionsRptF990Amt
Method Of Determining Revenues	FAIR MARKET VALUE	MethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp (2 entries)

Non Cash CheckboxNonCashCheckboxInd	DescDesc	ContributionContributionCnt	Noncash Contributions Rpt F990NoncashContributionsRptF990Amt	Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)	VARIOUS OTHER	9	$59,309	FAIR MARKET VALUE
Yes (X)	PRINTED ITEMS	1	$2,500	FAIR MARKET VALUE

Field	Value	IRS element (for citing)
Form8283 Received	0	Form8283ReceivedCnt
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (1)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	0	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	SCHEDULE M - SUPPLEMENTAL INFORMATION PART I, COLUMN B	FormAndLineReferenceDesc
Explanation	LLS IS REPORTING THE NUMBER OF CONTRIBUTIONS FOR EACH OF THE ITEMS IN PART I, NOT THE NUMBER OF INDIVIDUAL ITEMS.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 4	DURING THE TAX YEAR, LLS AMENDED ITS BYLAWS EFFECTIVE FEBRUARY 3, 2024. THE BYLAW AMENDMENTS INCLUDED THE CREATION OF AN OPERATIONS COMMITTEE OF THE BOARD OF DIRECTORS TO OVERSEE LLS' OPERATIONAL PLANS, DESIGNATED OFFICER POSITIONS FOR LLS' GENERAL COUNSEL AND CHIEF PEOPLE OFFICER AND INCLUDED A REQUIREMENT THAT A CHAIRPERSON AND VICE CHAIRPERSON MUST SERVE AS A DIRECTOR FOR 1 TERM PRIOR TO THEIR ELECTION TO THE POSITION.
FORM 990, PART VI, SECTION B, LINE 11B	THE FORM 990 WAS PREPARED BY THE LLS FINANCE DEPARTMENT AND WAS REVIEWED BY THE CFO, SENIOR VICE PRESIDENT OF FINANCE, VICE PRESIDENT, CONTROLLER, AND KPMG FOR COMMENT AND SUGGESTED REVISIONS. THE FORM 990 WAS THEN PROVIDED TO THE AUDIT COMMITTEE, WHICH IS A COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWED THE 990 AND PROVIDED INPUT PRIOR TO FILING. THE FINAL DRAFT FORM 990, AS WILL BE FILED WITH THE IRS, WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12C	ALL EMPLOYEES, VOLUNTEERS, CONSULTANTS, TEMPORARY EMPLOYEES, LOCAL BOARD MEMBERS, AND MEMBERS OF THE NATIONAL BOARD OF DIRECTORS ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY ON AN ANNUAL BASIS AND SUBMIT A SIGNED FORM ACKNOWLEDGING THAT THEY HAVE REVIEWED THE POLICY AND DISCLOSED ANY CONFLICTS OF INTEREST. ALL CONFLICT OF INTEREST DISCLOSURE FORMS ARE REVIEWED BY THE LEGAL DEPARTMENT AND, IF DEEMED NECESSARY, ESCALATED TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS FOR FURTHER REVIEW, EVALUATION, AND/OR MANAGEMENT OF ANY ACTUAL OR APPARENT CONFLICTS OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	THE TALENT AND COMPENSATION COMMITTEE COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS REVIEWS, MONITORS, AND APPROVES THE CHIEF EXECUTIVE OFFICER'S PERFORMANCE AND COMPENSATION. THEIR DECISION IS INCLUDED IN THE APPROPRIATE MINUTES OF THE MEETING IN WHICH APPROVAL WAS GIVEN. IN JUNE 2023, THE TALENT AND COMPENSATION COMMITTEE, THROUGH AN INDEPENDENT THIRD PARTY, OBTAINED A MARKET STUDY COMPRISED OF SIMILAR NOT-FOR-PROFIT ORGANIZATIONS TO REVIEW THE COMPENSATION MARKET LEVELS AND SET THE CHIEF EXECUTIVE'S SALARY COMMENSURATELY. THE COMMITTEE MET, APPROVED AND DOCUMENTED THE PROCESS IN THE COMMITTEE MINUTES. IN 2023, THE TALENT AND COMPENSATION COMMITTEE, THROUGH AN INDEPENDENT THIRD PARTY, OBTAINED A MARKET STUDY COMPRISED OF SIMILAR NOT-FOR-PROFIT ORGANIZATIONS TO REVIEW THE COMPENSATION MARKET LEVELS OF OTHER OFFICERS AND KEY EMPLOYEES AND TO APPROVE THE PRESIDENT AND CEO'S RECOMMENDATIONS ON THEIR COMPENSATION LEVELS.
FORM 990, PART VI, SECTION C, LINE 19	THE LEUKEMIA & LYMPHOMA SOCIETY, INC. MAKES ITS ANNUAL FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE AT WWW.LLS.ORG. ITS GOVERNING DOCUMENTS ARE MADE AVAILABLE UPON REQUEST FOR PUBLIC INSPECTION. ANY IDENTIFIED CONFLICTS OF INTEREST ARE DISCLOSED IN THE 990.
FORM 990, PART IX, LINE 11G	OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 14,796,303. MANAGEMENT AND GENERAL EXPENSES 3,927,127. FUNDRAISING EXPENSES 3,169,711. TOTAL EXPENSES 21,893,141.
FORM 990, PART XI, LINE 9:	FOREIGN CURRENCY ADJUSTMENTS 335,200.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (7 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
BEAT AML LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	NY	$4,987,820	-$56,200	LLS
LLS PEDAL INITIATIVE LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	NY	$10,885,329	$3,394,697	LLS
LLS TAP MIRAGEN LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			LLS
LLS TAP X4 LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			LLS
LLS TAP LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE	$931,402	$10,401,740	LLS
LLS TAP CONSTELLATION LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			LLS
LLS TAP KDAC LLC
1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	RESEARCH	DE			LLS

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1ForeignAddress/AddressLine1Txt	CityForeignAddress/CityNm	CountryForeignAddress/CountryCd	Foreign PostalForeignAddress/ForeignPostalCd	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile Foreign CountryLegalDomicileForeignCountryCd	Direct Controlling NADirectControllingNACd	Controlled OrganizationControlledOrganizationInd	Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
THE LLS OF CANADA
804 2 LANSING SQUARE	TORONTO	CA	M2J4P8	PART VII	CA	N/A	0
THE LLS RESEARCH FOUNDATION
				PART VII			Yes (1)	1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	133709252	DE	501(C)(3)	LINE 12A, I	LLS INC
THE LLS RESEARCH PROGRAMS INC
				PART VII			Yes (1)	1201 15TH STREET NW SUITE 410	WASHINGTON	DC	20005	133470494	DE	501(C)(3)	LINE 12A, I	LLS INC

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	0	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	0	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	0	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	0	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	0	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	0	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	0	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	0	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	0	SharingOfFacilitiesInd
Paid Employees Sharing	0	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (1)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd